Interestingly, proteolytic fragments of all three collagen types or perlecan restrict angiogenesis especially in cancer [209–216], which may concurrently normalize the tumor microvasculature and reduce vessel leakiness as observed previously when interfering with experimental tumor angiogenesis [172]. The gene discussed is HSPG2; the disease is neoplasm.